CANDRIAM S.C.A. – Iovance Biotherapeutics, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$15.99M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
-13.22%
quarter
Iovance Biotherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.46% | 40K shares | -1.99M | $9.58 | 1.66M |
| Q2 2022 | share | Increase | +41.33% | 476.33K shares | -1.20M | $11.04 | 1.62M |
| Q1 2022 | share | Increase | +28.58% | 256.22K shares | 2.07M | $16.65 | 1.15M |
| Q4 2021 | share | Increase | +5.62% | 47.71K shares | -3.81M | $19.42 | 896.36K |
| Q3 2021 | share | Decrease | -16.83% | -171.77K shares | -5.62M | $24.66 | 848.65K |
| Q2 2021 | share | Increase | +72.36% | 428.38K shares | 165K | $26.02 | 1.02M |
| Q1 2021 | share | Decrease | -0.00% | -25 shares | -1.08M | $31.66 | 592.03K |
| Q4 2020 | share | Decrease | -13.58% | -93.01K shares | 4.92M | $46.4 | 592.06K |
| Q3 2020 | share | Decrease | -9.58% | -72.57K shares | 1.75M | $32.92 | 685.08K |
| Q2 2020 | share | Increase | +336.68% | 584.15K shares | 16.10M | $27.45 | 757.65K |
| Q1 2020 | share | Increase | +0.01% | 26 shares | -107K | $29.94 | 173.50K |
| Q4 2019 | share | Increase | +149.61% | 103.97K shares | 3.53M | $27.68 | 173.47K |
| Q3 2019 | share | Increase | +44.79% | 21.5K shares | 93K | $18.2 | 69.5K |
| Q2 2019 | share | Increase | 0.00% | 48K shares | 1.17M | $24.52 | 48K |
| Q3 2018 | share | Decrease | -100.00% | -112K shares | -1.43M | $11.25 | 0 |
| Q2 2018 | share | Increase | +15.46% | 15K shares | -205K | $12.8 | 112K |
| Q1 2018 | share | Increase | 0.00% | 97K shares | 1.63M | $16.9 | 97K |